VT
VistaGen Therapeutics Inc
🇺🇸XNAS.VTGNUnited StatesHealthcare
$0.24USDunchanged 0.00 (0%)OpenDelayed5:45 PM
Price$0.240.00 (0%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US92840H4002
- CUSIP
- 92840H103
Company
- Employees
- 41
- Headquarters
- South San Francisco, United States
- Website
- https://www.vistagen.com
- CEO
- Mr. Shawn K. Singh J.D.
Market
- Shares outstanding
- 44.4M
- Market cap
- $10.65M
Highlights
- Market cap
- $10.65M
- EPS LTM
- -$1.57
- P/E LTM
- -0.13
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $2.5M+287.31%up year on year
- Net income
- -$67.62M-21.23%down year on year
- Gross margin
- 69.02%+22,395%up year on year
- Free cash flow
- -$62.3M-24.13%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.